A detailed history of California State Teachers Retirement System transactions in Nuvalent, Inc. stock. As of the latest transaction made, California State Teachers Retirement System holds 28,333 shares of NUVL stock, worth $2.48 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28,333
Previous 28,870 1.86%
Holding current value
$2.48 Million
Previous $2.19 Million 32.33%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$67.44 - $112.17 $36,215 - $60,235
-537 Reduced 1.86%
28,333 $2.9 Million
Q2 2024

Aug 14, 2024

BUY
$62.76 - $81.61 $185,330 - $240,994
2,953 Added 11.39%
28,870 $2.19 Million
Q1 2024

May 15, 2024

SELL
$72.35 - $88.99 $92,897 - $114,263
-1,284 Reduced 4.72%
25,917 $1.95 Million
Q4 2023

Feb 13, 2024

BUY
$42.42 - $80.28 $156,614 - $296,393
3,692 Added 15.7%
27,201 $2 Million
Q3 2023

Nov 14, 2023

SELL
$39.12 - $49.85 $99,012 - $126,170
-2,531 Reduced 9.72%
23,509 $1.08 Million
Q2 2023

Aug 21, 2023

SELL
$23.58 - $44.68 $37,916 - $71,845
-1,608 Reduced 5.82%
26,040 $1.1 Million
Q1 2023

May 09, 2023

BUY
$25.42 - $33.52 $119,041 - $156,974
4,683 Added 20.39%
27,648 $721,000
Q4 2022

Feb 14, 2023

BUY
$18.46 - $36.37 $300,639 - $592,321
16,286 Added 243.84%
22,965 $683,000
Q3 2022

Nov 18, 2022

SELL
$13.55 - $19.92 $7,547 - $11,095
-557 Reduced 7.7%
6,679 $130,000
Q2 2022

Aug 15, 2022

SELL
$7.4 - $15.07 $4,255 - $8,665
-575 Reduced 7.36%
7,236 $98,000
Q1 2022

May 16, 2022

BUY
$11.65 - $19.57 $23,579 - $39,609
2,024 Added 34.97%
7,811 $108,000
Q3 2021

Nov 15, 2021

BUY
$18.25 - $38.35 $105,612 - $221,931
5,787 New
5,787 $130,000

Others Institutions Holding NUVL

About Nuvalent, Inc.


  • Ticker NUVL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,977,800
  • Market Cap $3.76B
  • Description
  • Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...
More about NUVL
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.